Ryuzo Hanada

The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-co

O. Nemoto, M. Furue, Hidemi Nakagawa et al. · British Journal of Dermatology · 2015 · 189 citations · Full text

Medicine, Dermatology, Pharmacology +17

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults

Masanari Shiramoto, Ryuzo Hanada, Christine Juergens et al. · Human Vaccines & Immunotherapeutics · 2015 · 46 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Acute Dose–Response Effectiveness of Combined Catechins and Chlorogenic Acids on Postprandial Glycemic Responses in Healthy Men: Results from Two Randomized Studies

Aya Yanagimoto, Yuji Matsui, Tohru Yamaguchi et al. · Nutrients · 2023 · 20 citations · Full text

Medicine, Endocrinology, Nutritional Sciences +14

Celecoxib Monotherapy Maintained Small Intestinal Mucosa Better Compared With Loxoprofen Plus Lansoprazole Treatment

Shunji Fujimori, Ryuzo Hanada, Mari Hayashida et al. · Journal of Clinical Gastroenterology · 2015 · 15 citations

Medicine, Pharmacology, Pharmacotherapy +13

Arrhythmias observed during high-G training: proposed training safety criterion.

Ryuzo Hanada, Tetsuya Hisada, Tetsuya Tsujimoto et al. · PubMed · 2004 · 13 citations

Medicine, Cardiology, Physiology +12